Showing 1 – 20 of 90
SORT: Best Match Most Recent Oldest
VIEW: Basic | Expanded
  • Original Investigation February 19, 2014

    Anton P. Porsteinsson, MD; Lea T. Drye, PhD; Bruce G. Pollock, MD, PhD; D. P. Devanand, MD; Constantine Frangakis, PhD; Zahinoor Ismail, MD; Christopher Marano, MD; Curtis L. Meinert, PhD; Jacobo E. Mintzer, MD, MBA; Cynthia A. Munro, PhD; Gregory Pelton, MD; Peter V. Rabins, MD; Paul B. Rosenberg, MD; Lon S. Schneider, MD; David M. Shade, JD; Daniel Weintraub, MD; Jerome Yesavage, MD; Constantine G. Lyketsos, MD, MHS; for the CitAD Research Group
    TOPICS: alzheimer's disease, citalopram, agitation

    JAMA. 2014; 311(7):682-691. doi: 10.1001/jama.2014.93

    Includes: Multimedia, Supplemental Content
  • ARTICLE November 11, 1983

    Martin L. Lee, FSS, PhD

    JAMA. 1983; 250(18):2470-2470. doi: 10.1001/jama.1983.03340180032013

  • Comment & Response September 03, 2014

    Alison Poulton, MD, MBBChir, MA; Deepak Kumar Rai, MD, DCh; Kate Venter, MBBS, BMedSci

    JAMA. 2014; 312(9):962-962. doi: 10.1001/jama.2014.8745

  • ARTICLE November 11, 1983

    Ilo E. Leppik, MD; Albert T. Derivan, MD

    JAMA. 1983; 250(18):2470-2470. doi: 10.1001/jama.1983.03340180032014

  • In This Issue of JAMA April 23, 2014

    JAMA. 2014; 311(16):1581-1583. doi: 10.1001/jama.2013.279458